Monday, 24 Feb 2020


Datesort descending Type Title Save
15 Apr 2016 News Does Psoriasis Increase Risk of Abdominal Aneurysm?
22 Apr 2016 Social Treatment options for active Ankylosing spondylitis: 1) Optimal dose NSAIDs; 2) TNF inhibitor; 3) Secukinumab; 4) ustekinumab (off label)
26 Apr 2016 News Low Adherence to Biologics in Psoriasis Patients
29 Apr 2016 Social Extensive skin psoriasis is a risk factor for Psoriatic Arthritis - other risk factors nail dz, obesity & smoking
02 May 2016 News Simple Referral Rule May Lead to Earlier Referral and Diagnosis of Axial Spondyloarthritis
02 May 2016 Social Health Canada approves secukinumab for use in psoriatic arthritis and anklylosing spondylitis
05 May 2016 News Methotrexate Yields No Added Benefit in Etanercept Treated Psoriatic Arthritis Patients
05 May 2016 Social Spondyloarthritis & Psoriatic arthritis pts (from ARTIS & DANBIO) show NO cancer risk & TNFi does not augment this.
09 May 2016 Social Genetic overlap betw anklyosing spondylitis & IBD shown in exom sequencing of 4602 AS patients; Philip Robinson etal
12 May 2016 Social CORRONA & NPF sign on for a postmarketing safety registry of >4000 Psoriasis pts on Taltz (ixekizumab)
12 May 2016 News Secukinumab Improves Patient-Reported Outcomes in Psoriatic Arthritis (FUTURE 1)
19 May 2016 Social @DrPetryna Calprotectin (stool or serum) a biomarker in IBD, used to identify bowel inflammation in SpA patients
27 May 2016 Social Review of 164 SAPHO pts. Most common:palmoplantar pustulosis > severe acne, Chest wall pain > LBP, 70% ^CRP, 2% B27+
08 Jun 2016 News EULAR: Tofacitinib Effective in Ankylosing Spondylitis
08 Jun 2016 Social Secukinumab data presented at EULAR; Novartis plans H2H trial of Cosentyx & Humira; details to follow
12 Jun 2016 Social Drs Braun & van der Heidje review efficacy & imaging benefits of Cosentyz & Xeljanz in Ank Spondylitis at #EULAR2016
13 Jun 2016 News No Increased Risk of Colitis Flares in Secukinumab Trials
17 Jun 2016 Social Swedish registries show (like RA) ankylosing spondylitis is assoc w/ 30%–50% increased risk of incident CV events.
25 Jun 2016 News AS Diagnosis Linked to CVD Risk
27 Jun 2016 Social RAPID3 gives similar outcome info to BASDAI and ASDAS in a cross sectional study of 85 AS patients